GLIPR1

GLIPR1

Target · Pathogenesis-related protein

GLIPR1 GLI pathogenesis related 1 · Glioma pathogenesis-related protein 1

GLIPR1 (glioma pathogenesis-related protein 1) is a membrane protein related to both the pathogenesis-related protein superfamily and the cysteine-rich secretory protein (CRISP) family. It is also known as RTVP1 and GliPR, and has been studied for its proapoptotic activity in cancer cells. Browse Assay Genie's current range of GLIPR1 research reagents below, or read on for the biology behind the target.

Membrane proteinCRISP family memberProapoptotic in tumour cells
266 aa
Protein length
~30 kDa
Molecular weight
12q21.2
Gene locus
CRISP family
Protein family
Target information

What is GLIPR1 (GLI pathogenesis related 1)?

GLIPR1 encodes a protein with similarity to both the pathogenesis-related protein (PR) superfamily and the cysteine-rich secretory protein (CRISP) family, and UniProt places it in the CRISP family. The protein is annotated as a membrane protein. Reported activities centre on apoptosis: the GLIPR1 protein has proapoptotic effects in prostate and bladder cancer cells.

The GLIPR1 gene is linked to cell differentiation and to cancer biology. Increased expression is associated with myelomonocytic differentiation in macrophages, whereas decreased expression through gene methylation is associated with prostate cancer. This pattern has made GLIPR1 a subject of interest in studies of tumour suppression and epigenetic regulation.

HGNC classes the gene in the GLIPR family, under the name GLI pathogenesis related 1, previously GLI pathogenesis-related 1 (glioma). The gene belongs to a cluster on chromosome 12 that contains two other similar genes, one of which is related to GLIPR2 in the same family naming scheme. Alternatively spliced variants encoding different protein isoforms have been described, although not all variants have been fully characterised. The mouse ortholog is Glipr1.

Prostate cancer research

Reduced GLIPR1 expression through gene methylation is associated with prostate cancer, making it relevant to studies of epigenetic silencing.

Apoptosis studies

GLIPR1 has proapoptotic activity in prostate and bladder cancer cells, supporting work on cell death mechanisms in tumours.

Bladder cancer biology

The protein's proapoptotic activity in bladder cancer cells makes it a candidate for investigating tumour cell survival.

Macrophage differentiation

Increased GLIPR1 expression is associated with myelomonocytic differentiation in macrophages, linking it to myeloid cell biology.

Background

GLIPR1 frequently asked questions

What does GLIPR1 do?

GLIPR1 is a membrane protein of the CRISP family with similarity to pathogenesis-related proteins. It has proapoptotic activity in prostate and bladder cancer cells, and its expression is associated with myelomonocytic differentiation in macrophages. Its detailed molecular function is not described in the sources used here.

What other names does GLIPR1 go by, and does it have isoforms?

GLIPR1 is also called RTVP1, GliPR and glioma pathogenesis-related protein 1; the earlier HGNC name was GLI pathogenesis-related 1 (glioma). Alternatively spliced variants encoding different protein isoforms have been described, though not all have been fully characterised.

Is GLIPR1 linked to disease, and is it conserved in mouse?

Decreased GLIPR1 expression through gene methylation is associated with prostate cancer. The mouse ortholog is Glipr1, so rodent models can be used to study the gene. Check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other members of the GLIPR family with products at Assay Genie.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P48060; product specifications from Assay Genie datasheets.

GLIPR1 Product listing